Labwire Completes First Conversion of USIS Business
30 Junio 2008 - 1:18PM
Marketwired
HOUSTON, TX , a leading provider of employee screening solutions
and canine security and surveillance services, announced today that
it has completed the first conversion of business under the USIS
agreement.
"This is a very important accomplishment for us," commented Mr.
Dexter Morris, Chairman and Chief Executive Officer of Labwire.
"Our team worked well with USIS personnel, and the conversion was
completed smoothly and on schedule. We are already planning the
next interfaces and data transfers and exploring additional
business possibilities with USIS. I am very excited about the
potential of this strategic relationship."
About Labwire:
Labwire, Inc., Headquartered in Houston, TX, provides secure and
compliant employee drug screening and background checking services
to Fortune 500 corporations via the Labwire(TM) Platform.
Labwire(TM) is a proprietary, web-based application that
streamlines the complex regulatory and record management activities
associated with employee screening, delivering accurate timely
results while eliminating service calls and paper trails. This
comprehensive solution to managing employee screening services is
the most efficient and cost-effective platform in the industry.
About USIS:
USIS is a worldwide provider of total client solutions in human
resources background investigations, pre-employment/drug screening,
insurance information services, due diligence and risk management
assessment, and security and related professional services to
businesses, federal agencies and institutions. Formerly the Office
of Federal Investigations (a U.S. government agency privatized in
1996), today USIS remains the largest supplier of security
investigations to the U.S. government and a major global provider
of security support services, training and consulting solutions for
government agencies and commercial clients. Headquartered in Falls
Church, Va., USIS has approximately 7,000 employees supporting
business operations in all 50 states and overseas. For more
information, please visit www.usis.com.
Safe Harbor Provisions:
Certain oral statements made by management from time to time and
certain statements contained in press releases and periodic reports
issued by Labwire, Inc., (the "Company"), as well as those
contained herein, that are not historical facts are
"forward-looking statements" within the meaning of Section 21E of
the Securities and Exchange Act of 1934 and, because such
statements involve risks and uncertainties, actual results may
differ materially from those expressed or implied by such
forward-looking statements. Forward-looking statements, including
those in Management's Discussion and Analysis, are statements
regarding the intent, belief or current expectations, estimates or
projections of the Company, its Directors or its Officers about the
Company and the industry in which it operates, and are based on
assumptions made by management. Forward-looking statements include
without limitation statements regarding: (a) the Company's
strategies regarding growth and business expansion, including
future acquisitions; (b) the Company's financing plans; (c) trends
affecting the Company's financial condition or results of
operations; (d) the Company's ability to continue to control costs
and to meet its liquidity and other financing needs; (e) the
declaration and payment of dividends; and (f) the Company's ability
to respond to changes in customer demand and regulations. Although
the Company believes that its expectations are based on reasonable
assumptions, it can give no assurance that the anticipated results
will occur. When issued in this report, the words "expects,"
"anticipates," "intends," "plans," "believes," "seeks,"
"estimates," and similar expressions are generally intended to
identify forward-looking statements.
Important factors that could cause the actual results to differ
materially from those in the forward-looking statements include,
among other items, (i) changes in the regulatory and general
economic environment; (ii) conditions in the capital markets,
including the interest rate environment and the availability of
capital; (iii) changes in the competitive marketplace that could
affect the Company's revenue and/or cost and expenses, such as
increased competition, lack of qualified marketing, management or
other personnel, and increased labor and inventory costs; (iv)
changes in technology or customer requirements, which could render
the Company's technologies noncompetitive or obsolete; (v) new
product introductions, product sales mix and the geographic mix of
sales.
The Company disclaims any intention or obligation to update or
revise forward-looking statements, whether as a result of new
information, future events or otherwise. Safe Harbor Statement
under the Private Securities Litigation Reform Act of 1995: The
statements which are not historical facts contained in this
advertisement are forward-looking statements that involve certain
risks and uncertainties including but not limited to risks
associated with the uncertainty of future financial results,
additional financing requirements, development of new products,
governmental approval processes, the impact of competitive products
or pricing, technological changes, and the effect of economic
conditions.
Investor and Public Relations Contact: Marlin R. Williford Jr.
email: mwilliford@capnetrisk.com Phone: (832) 487-7803
Labwire (CE) (USOTC:LBWR)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Labwire (CE) (USOTC:LBWR)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024